Table I.
Clinicopathological characteristics of patients with GC and healthy volunteers.
| Sample ID | Age, years | Sex | Histological type | Histological grade | TNM stage |
|---|---|---|---|---|---|
| GC | |||||
| GC190121 | 71 | Male | Adenocarcinoma | Poorly | T4aN3aM0 IIIB |
| GC190122 | 58 | Male | Adenocarcinoma | Poorly | T2N1M0 IIA |
| GC190124 | 63 | Male | Adenocarcinoma | Poorly | T3N2MO IIIA |
| GC190125-2 | 64 | Male | Adenocarcinoma | Poorly | T4aN3aM0 IIIB |
| GC190128-2 | 65 | Male | Adenocarcinoma | Poorly | T3N3aMO IIIB |
| HC | |||||
| HC190128-1 | 33 | Male | |||
| HC190128-2 | 43 | Male | |||
| HC190128-3 | 29 | Male | |||
| HC190128-4 | 26 | Male | |||
| HC190128-5 | 37 | Male |
HC, healthy control; GC, gastric cancer; TNM, Tumor-Node-Metastasis.